Virbac SACA

VIRBAC: exceptional first-half momentum (+16.2% at constant exchange rates) driven by all regions

16 Jul 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac: Termination of the liquidity contract

11 Jul 2024 10:32:53 By Nasdaq GlobeNewswire

VIRBAC: exceptional first-half growth and guidance raised for 2024

08 Jul 2024 02:30:00 By Nasdaq GlobeNewswire

VIRBAC announces executive management changes

08 Jul 2024 02:30:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 06/2024

05 Jul 2024 12:48:48 By Nasdaq GlobeNewswire

Virbac finalizes minority shares’ acquisition of Globion, an Indian poultry vaccines specialist

02 Jul 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 05/2024

06 Jun 2024 07:08:50 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights

06 May 2024 04:28:21 By Nasdaq GlobeNewswire

Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)

24 Apr 2024 12:00:00 By Nasdaq GlobeNewswire

VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates

16 Apr 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 03/2024

09 Apr 2024 08:46:42 By Nasdaq GlobeNewswire

Virbac acquired Sasaeah, a leading animal health player in Japan

02 Apr 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023

19 Mar 2024 13:00:00 By Nasdaq GlobeNewswire

VIRBAC: 2023 ANNUAL RESULTS

19 Mar 2024 12:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 02/2024

11 Mar 2024 06:03:01 By Nasdaq GlobeNewswire

Virbac to take a leading position in Japan through the acquisition of Sasaeah

06 Mar 2024 02:20:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 01/2024

06 Feb 2024 09:54:53 By Nasdaq GlobeNewswire

VIRBAC: Annual revenue growth of +4.9% thanks to record fourth-quarter activity at +11.5%

17 Jan 2024 11:45:00 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 12/2023

08 Jan 2024 05:09:10 By Nasdaq GlobeNewswire

Outlook 2023-2024

19 Dec 2023 02:30:00 By Nasdaq GlobeNewswire